National Stockpiles Affect Medicine Access in Some EU Countries
Medicines for Europe shared on LinkedIn:
”Fragmented national stockpiling policies are making essential medicines harder to access in some EU countries, extending shortages and exposing our internal market.
In Germany, a 6-month stockpile equals almost 2 years’ supply for the Netherlands. Uncoordinated stockpiling risks destabilizing smaller markets and reducing treatment availability in other regions.
For example, 70% of companies have observed longer stockout periods and reduced availability of medicines in smaller markets, due to stockpiling requirements.
We need a unified approach to ensure timely and equal access for patients, as well as robust supply chains based on proportionate measures and EU solidarity.
Check out our report to learn more.”
Find more posts on Hemostasis Today.
-
Feb 1, 2026, 13:32Shiny K. Kajal: A Series On Reaching the Diagnosis of Immune Thrombocytopenia
-
Feb 1, 2026, 13:26Mary Cushman: Association of Atrial Fibrillation with Risk of Incident Cognitive Impairment
-
Feb 1, 2026, 13:23Abdulrahman Katib: Extended Low-Dose DOAC May Reduce VTE Recurrence
-
Feb 1, 2026, 13:22Jeff June: The Stroke That Wasn’t New – Why ‘Cryptogenic’ Often Means Undetected
-
Feb 1, 2026, 13:11Panagiotis Doukas: Plasma Desmosine as a Biomarker of Increased Proteolytic Activity in the Aortic Wall
-
Feb 1, 2026, 12:54Pierpaolo Di Micco: Starting a New Era for Anticoagulant Treatments
-
Feb 1, 2026, 12:16Erwin Loh: Immunotherapy Reduces Plaque in Arteries of Mice
-
Feb 1, 2026, 12:06Ney Carter Borges: The Central Role of Endothelial Dysfunction in Cardiovascular Disease Progression
-
Feb 1, 2026, 12:05Causes of Anemia – A Quick Overview From Mahnoor Shah